# Ubiquitin and Regulated Proteolysis as Signals

> Signals change protein fate by changing what an E3 can recognize. This lesson follows the E1, E2 and E3 relay, shows how phosphorylation, oxygen and auxin change target recognition, and explains why different ubiquitin marks destroy, move or assemble proteins. Afterwards you can trace oxygen sensing and auxin sensing from the signal to the gene.

Course: Cell Signaling (The parts: switches and wiring). Level: advanced university and graduate. About 19 minutes.
Lesson page (link this one when citing): https://stemhop.com/lessons/ubiquitin-and-proteolysis/

Builds on: Phosphorylation: Kinases and Phosphatases · GTPase Switches: The Timer

## What you'll learn

- Describe the E1, E2 and E3 cascade and say where the specificity lives.
- Explain how a signal writes a degron that an E3 recognizes, using a phosphorylated inhibitor and oxygen-dependent hydroxylation of HIF-1α as examples.
- Distinguish the ubiquitin marks that send a protein to the proteasome from those that move or assemble proteins.
- Explain why irreversible destruction is a useful way for a signaling pathway to act.

The first film showed oxygen marking one protein, HIF-1α, for destruction. HIF-1α is a transcription factor, a protein that switches genes on, and it turns on the genes a cell needs when oxygen runs short. This lesson is about that one-way switch and how a signal writes it.

## One recognition step can change a protein’s fate

**Ubiquitin** is a small protein, 76 amino acids long, attached to other proteins as a tag. The **proteasome** is a barrel-shaped protease that destroys proteins carrying an appropriate ubiquitin signal. A **degron** is the feature the tagging machinery recognizes on a target: a short sequence, a chemical change or both.

> **The one idea.** Signals change protein fate by changing what an E3 can recognize.
>
> *Scope:* this rule covers the regulated ubiquitin pathways in this lesson. A signal may complete a degron or strengthen an E3-target contact. The mark built afterward also helps determine the outcome.

Proteolysis makes the choice costly to reverse. A phosphate can be removed, and a ubiquitin mark can be cut off before degradation. Once a protein is cut into peptides, only a newly made copy replaces it. Destroying an inhibitor can free a pathway until new inhibitor is made; destroying an activator can end a signal until it is replaced. A cell leaves mitosis by destroying cyclin B, which keeps it there.

The earlier lesson on [protein turnover and amino acid catabolism](https://stemhop.com/lessons/protein-turnover-amino-acid-catabolism/) covers proteasome mechanics and ubiquitin’s discovery.

## The bonds and branches behind the relay

The film showed the handoff; here are the bonds. **E1**, the activating enzyme, spends ATP to join ubiquitin’s carboxyl end, glycine 76, to one of its own cysteines. That temporary **thioester** is an energy-rich sulfur-carbonyl bond. E1 passes ubiquitin to a cysteine on **E2**, the conjugating enzyme. **E3**, the ligase, completes the transfer, usually by an **isopeptide bond**: an amide between ubiquitin’s C-terminus and a target lysine side chain rather than the backbone.

Human cells have two E1s, about forty E2s and roughly six hundred predicted E3s. One E1 supplies nearly the whole system, while each E3 recognizes a set of degrons. For the examples here, most target specificity sits in the E3 or its substrate receptor.

E3s have two main designs. A **RING-type** ligase holds loaded E2 beside the target, so ubiquitin passes directly across. A **HECT-type** ligase first takes ubiquitin onto its own cysteine. **SCF ligases** are RING-type: a cullin scaffold holds a small RING protein that docks E2, the adaptor Skp1 and an interchangeable F-box protein that binds the degron.

**Predict.** Mixed with ubiquitin-loaded E2, an E3 first carries ubiquitin as a short-lived thioester on one of its own cysteines before the target receives it. Is the E3 RING-type or HECT-type?

> **Check your prediction.** HECT-type. A HECT ligase accepts ubiquitin from E2 onto its catalytic cysteine, then transfers it to the target. A RING ligase never holds ubiquitin itself; it promotes direct transfer from E2 to the target.

*Figure (AI-generated illustration).* Swapping the F-box protein redirects the same SCF core toward a different degron and target. Image: a labelled SCF ligase with a cullin scaffold, RING protein, E2 carrying ubiquitin, Skp1 adaptor and clay F-box protein gripping a target, with an inset showing a different F-box gripping a different target.

After the first ubiquitin, more can be added to a lysine on the preceding ubiquitin. Ubiquitin has seven lysines, and chains can also join through its first amino acid, methionine 1. Linkage, length and branching shape how a mark is read. A chain joined through lysine 48 and at least four ubiquitins long is a usual proteasome signal.

## Signals write recognizable degrons

Some regulated targets carry an incomplete degron that a signal completes.

**Phosphorylation can complete a docking site.** Some inhibitors have a short sequence containing two serines. The F-box protein β-TrCP binds only when both serines are phosphorylated. A signal-activated kinase adds the phosphates, and β-TrCP brings the inhibitor to an SCF for a lysine-48 chain and proteasomal destruction. IκB, inhibitor of NF-κB, is the classic case, followed in the NF-κB lesson. The Wnt lesson uses the same logic for β-catenin, except its signal stops phosphorylation. The reversible phosphate reads the signal; destruction commits that target molecule.

**Predict.** Both degron serines are replaced by alanines, but the kinase and proteasome still work. What step fails first?

> **Check your prediction.** Phosphorylation fails first: alanine has no hydroxyl, so the active kinase cannot add phosphates. Without them β-TrCP cannot recognize the degron, so the inhibitor never reaches the SCF.

**Oxygen-dependent hydroxylation completes another docking site.** Gregg Semenza found hypoxia-inducible factor 1 (HIF-1) while studying erythropoietin, the kidney hormone that tells bone marrow to make red blood cells. Its subunit HIF-1α was made continuously and destroyed rapidly when oxygen was available, so its standing amount changed with oxygen.

VHL is mutated in an inherited cancer syndrome, and cells lacking it made oxygen-regulated messages at high levels in ordinary air. VHL, the substrate receptor of a cullin-RING ligase, plays the role an F-box protein plays in an SCF, so it had to be reading some degron on HIF-1α. The film’s peptide test named it: a hydroxylated proline, recognized with no cell extract present.

**Prolyl hydroxylases**, or PHDs, add that hydroxyl. The reaction needs iron, 2-oxoglutarate and one molecule of oxygen. Oxygen is a substrate, used up like flour in bread; no separate oxygen receptor is required. Falling oxygen lowers how often PHDs finish the reaction, so VHL has less to grip and HIF-1α builds up while synthesis continues. It pairs with ARNT in the nucleus and switches on genes including VEGF, a growth factor that drives new blood vessels.

A close relative, HIF-2α, is destroyed through the same hydroxylation and VHL pathway. In the body it is the main factor switching on erythropoietin, and in kidney cancers lacking VHL it is the main tumour driver.

*Figure (AI-generated illustration).* Phosphorylation lets β-TrCP recognize an inhibitor, while oxygen-dependent hydroxylation lets VHL recognize HIF-1α. Image: two columns. Left: a kinase adds two phosphates to the tail of an inhibitor protein, the F-box protein β-TrCP grips both phosphates, and the inhibitor gets a lysine-48 ubiquitin chain and goes to the proteasome. Right: the enzyme PHD uses oxygen to add a hydroxyl to HIF-1α, VHL grips the hydroxylated proline, and HIF-1α gets a ubiquitin chain and goes to the proteasome.

*Interactive on the lesson page:* HIF-1α — oxygen writes the destruction mark

### Production minus destruction

How fast can HIF-1α rise once destruction stops? Let a protein amount, P, be made at constant rate s and destroyed with first-order rate constant k:

> **dP/dt = s − k × P; at steady state P = s/k; half-life = 0.69/k.**

A larger k gives a lower steady state and a shorter response time.

**Predict.** Synthesis stays fixed while k falls to half its original value. What happens to steady-state P and the half-life?

> **Check your prediction.** Both double: the steady state becomes s/(k/2) = 2s/k, and the half-life becomes 0.69/(k/2), twice 0.69/k.

The second film asks what different ubiquitin marks make happen, then shows a hormone that changes target choice without modifying the target first.

**Film transcript: One Tag, Different Destinations**

### Film transcript: One Tag, Different Destinations

The first film showed oxygen changing what VHL could recognize. Why does one ubiquitin mark move a protein while another destroys it? Keep the same colors: yellow ubiquitin, grey targets, green E3 and red proteasome. Start with one ubiquitin attached to one lysine. This monoubiquitin mark seldom sends a protein to the proteasome. It more often changes location. On a growth-factor receptor, readers can help pull the receptor into the cell by endocytosis. Now reconnect the yellow blocks into the classic proteasome-directed linkage. A sufficiently long chain is a usual proteasome signal. The red barrel engages the marked protein and breaks it down.

This is the classic destruction route. Reconnect the same yellow blocks through another linkage, and the picture changes again. Ubiquitin-binding domains clamp onto this chain. Several proteins can gather around one scaffold. Signaling complexes and repair proteins at damaged DNA can assemble this way. Return to a receptor carrying only one yellow ubiquitin. Is that single mark enough to commit the receptor to the proteasome? Choose a destination before the picture moves.

Not usually. In this example, the single mark helps route the receptor into a vesicle. Movement and destruction can still cooperate later, because internalized receptors are often carried to lysosomes. The mark suggests an outcome; it does not guarantee one alone. So ubiquitin behaves as a context-dependent code. Linkage, chain length, branching, substrate and available readers all matter. A simple lookup table would show too much certainty. Keep the mark, its reader and the target together. A signal can also change recognition without modifying the target first. In plants, TIR1 is a green E3 receptor. An Aux/IAA repressor rests nearby, but their contact is weak without the hormone auxin.

Auxin fits into a pocket exactly where TIR1 and the repressor meet. The small gold signal fills their gap. Their grip tightens without building a separate cascade. Auxin acts as molecular glue at the target-receptor interface. The ligase now ubiquitinates the repressor, and the proteasome removes it. Auxin-responsive genes are released from repression. Here hormone detection and target recruitment happen in one binding step. The signal triggers destruction by tightening an E3 grip. These two ideas work together. The E3 chooses a recognized target, while the ubiquitin mark recruits particular readers. Ubiquitin marks route proteins; molecular glues change what an E3 grips.

Follow both questions to predict a target's fate.

From the film

- Ubiquitin marks route proteins; molecular glues change what an E3 grips.
- A single ubiquitin more often changes a protein's location than destroys it.
- A lysine-48 chain is a classic proteasome signal; a lysine-63 chain can assemble a complex.
- Auxin tightens TIR1's grip on a repressor, coupling detection to destruction.

## Ubiquitin marks remain editable

**Deubiquitinating enzymes** cut ubiquitin off and can trim lysine-48 chains.

**Predict.** A deubiquitinating enzyme removes a target’s lysine-48 chain before the proteasome engages it. Can the same protein molecule still be rescued? What if proteolysis has begun?

> **Check your prediction.** Before engagement, yes: chain removal rescues that molecule from this destruction signal. Once proteolysis has cut the protein, removing ubiquitin cannot rebuild it; a replacement must be made.

*Figure (AI-generated illustration).* A single ubiquitin often changes location, a classic lysine-48 chain targets the proteasome, and a lysine-63 chain can assemble readers. Image: three frames. One ubiquitin on a membrane receptor's tail goes with the receptor into a pinched-off vesicle. A lysine-48 chain of four ubiquitins leads a protein into the proteasome, which releases fragments. A lysine-63 chain has three different proteins clamped onto it. Below, scissors cut a ubiquitin off a chain.

**SUMO**, a small ubiquitin-like modifier of about 100 amino acids, is folded like ubiquitin and attached to lysines by its own E1, E2 and E3. It usually changes binding or location, though some SUMO chains are read by ubiquitin ligases that send the protein to the proteasome.

## Evidence that TIR1 is receptor and selector

The film called auxin a **molecular glue**, a small molecule that strengthens or creates a protein-protein contact. Auxin tells shoots which way to bend and roots where to grow. Botanists long sought its receptor at the cell surface, but the receptor behind its gene response is part of an SCF destruction machine.

Arabidopsis plants with a broken TIR1 gene respond poorly to auxin. TIR1 is an F-box protein, then thought to grab targets rather than sense hormones. In 2005 two laboratories independently showed that TIR1 binds auxin itself (see Going deeper). The relevant targets are Aux/IAA repressors, which hold auxin-responsive genes off.

A 2007 [crystal structure](https://stemhop.com/methods/x-ray-crystallography/) from Mark Estelle’s group with Ning Zheng confirmed the film’s picture: auxin sits where TIR1 and an Aux/IAA repressor meet.

**Predict.** Auxin and TIR1 bind normally, but the proteasome is blocked. Will the repressor disappear and the genes switch on by this route?

> **Check your prediction.** No. Recognition and ubiquitination can occur, but the repressor remains if the proteasome cannot destroy it, so the genes stay off.

Drug makers use the same principle. Lenalidomide, a thalidomide relative used in multiple myeloma, binds cereblon, a cullin-RING substrate receptor. The drug reshapes cereblon’s surface so it grips the transcription factors Ikaros and Aiolos, which it would otherwise ignore, and they are then ubiquitinated and destroyed. The drug was used clinically before this mechanism was known. **PROTACs** are two-headed molecules: one end binds a target, while the other binds a ligase such as VHL, using a small molecule built around the hydroxyproline VHL recognizes in HIF-1α.

### Design problem

A transcription factor must be nearly absent when oxygen is plentiful and enter the nucleus within minutes when oxygen falls. Design the control. Why destroy it continuously rather than make it on demand?

> **One way to do it.** Make the factor continuously and destroy it through an oxygen-dependent tag. Give it a five-minute half-life in air. Then k is about 0.14 per minute and 1/k about seven minutes, so the steady pool equals about seven minutes of synthesis.
>
> In this simple model, when oxygen falls, hydroxylation and destruction stop while synthesis continues. Each minute adds s to the existing s/k pool, about 14 percent of baseline. After 30 minutes the pool is about five times baseline, without waiting for new transcription.
>
> Making it on demand would wait tens of minutes to hours for transcription, RNA processing and translation. Continuous destruction also makes the off-switch as fast as the on-switch: when oxygen returns, the excess above baseline halves every five minutes, and after 25 minutes only about 3 percent of the excess is left. The cost is ATP and amino acids spent on discarded protein.

## Going deeper

### How VHL was tied to oxygen

Peter Ratcliffe’s group showed in 1999 that HIF-1α destruction depends on VHL and occurs efficiently when oxygen is available. William Kaelin reached VHL from the other direction, through the inherited cancer syndrome above.

### The degron and oxygen bookkeeping

In 2001 the two competing laboratories independently identified the hydroxylated degron. Proline 564 in human HIF-1α is one site; proline 402 is modified too. One oxygen atom enters the new hydroxyl. The other enters succinate when 2-oxoglutarate loses carbon dioxide.

### Where target choice really sits

E2-E3 pairing and the rest of the machinery can also influence ubiquitin transfer and chain architecture, so the E3 is the main selector in these pathways, not the only one.

### The auxin receptor papers

On 26 May 2005, Estelle’s laboratory at Indiana University and, independently, Ottoline Leyser and Stefan Kepinski at the University of York reported in the same issue of *Nature* that TIR1 binds auxin itself.

---

From STEMhop (https://stemhop.com), free lessons by Christopher Deppmann. Lesson text © the authors. Practice questions: https://stemhop.com/lessons/ubiquitin-and-proteolysis/
